Alternative Splicing of Titin Restores Diastolic Function in an HFpEF-Like Genetic Murine Model ( Ttn ΔIAjxn )
- 2 September 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 119 (6) , 764-772
Abstract
Rationale:: Patients with heart failure with preserved ejection fraction (HFpEF) experience elevated filling pressures and reduced ventricular compliance. The splicing factor RNA-binding motif 20 (RBM20) regulates the contour length of titin’s spring region and thereby determines the passive stiffness of cardiomyocytes. Inhibition of RBM20 leads to super compliant titin isoforms (N2BAsc) that reduce passive stiffness. Objective:: To determine the therapeutic potential of upregulating compliant titin isoforms in an HFpEF-like state in the mouse. Methods and Results:: Constitutive and inducible cardiomyocyte-specific RBM20–inhibited mice were produced on a Ttn ΔIAjxn background to assess the effect of upregulating compliant titin at the cellular and organ levels. Genetic deletion of the I-band–A-band junction ( IAjxn ) in titin increases strain on the spring region and causes a HFpEF-like syndrome in the mouse without pharmacological or surgical intervention. The increased strain represents a mechanical analog of deranged post-translational modification of titin that results in increased passive myocardial stiffness in patients with HFpEF. On inhibition of RBM20 in Ttn ΔIAjxn mice, compliant titin isoforms were expressed, diastolic function was normalized, exercise performance was improved, and pathological hypertrophy was attenuated. Conclusions:: We report for the first time a benefit from upregulating compliant titin isoforms in a murine model with HFpEF-like symptoms. Constitutive and inducible RBM20 inhibition improves diastolic function resulting in greater tolerance to exercise. No effective therapies exists for treating this pervasive syndrome; therefore, our data on RBM20 inhibition are clinically significant.Keywords
This publication has 39 references indexed in Scilit:
- Tuning the molecular giant titin through phosphorylation: Role in health and diseaseTrends in Cardiovascular Medicine, 2013
- RBM20, a gene for hereditary cardiomyopathy, regulates titin splicingNature Medicine, 2012
- Mouse intact cardiac myocyte mechanics: cross-bridge and titin-based stress in unactivated cellsJournal of General Physiology, 2010
- Truncation of Titin’s Elastic PEVK Region Leads to Cardiomyopathy With Diastolic DysfunctionCirculation Research, 2009
- An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in miceJournal of Clinical Investigation, 2008
- Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophyProceedings of the National Academy of Sciences, 2007
- Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection FractionNew England Journal of Medicine, 2006
- Extracellular Signal-Regulated Kinase 2 Interacts with and Is Negatively Regulated by the LIM-Only Protein FHL2 in CardiomyocytesMolecular and Cellular Biology, 2004
- Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2Journal of Cell Science, 2002
- Titin Isoform Switch in Ischemic Human Heart DiseaseCirculation, 2002